The treatment increased skin density and thickness, reduced fine lines and the depth of wrinkles, reduced photodamage and hyperpigmentation, improved skin clarity, and increased keratinocyte proliferation
GLP-1 (peptide-1 simile al glucagone)
353b), the FAQs state that compounding drugs, including GLP-1s, is appropriate either when the drug is not commercially available (including if there is an FDA-declared shortage) or when the compounded drug includes a change, made for an identified individual patient, which produces for that patient a significant difference, as determined by the prescribing practitioner, between the compounded drug and the commercially available product. In short, compounding pharmacies will no longer be able to produce copies of commercially available drugs, including GLP-1s
To reduce the chance of burning, avoid injecting into visibly irritated skin and give recently treated areas 24 to 48 hours to settle
Check for other causes